D Marquardt - Concepedia

Author

D Marquardt

Kansas State University

Also Known As

D Marquardt, D. Marquardt, David A. Marquardt, David Marquardt

Publications

511

Citations

H-Index

Concepts

All Affiliations

Kansas State University

About

D Marquardt is an author at Kansas State University specializing in medicine, cell biology, and cellular biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	414
2	Cell Biology	5	5	414
3	Natural Sciences	4	4	390
4	Biochemistry	4	4	390
5	Cellular Physiology	3	3	273

D Marquardt

Publications

500

Citations

H-Index

Page 1

	Year	Citations
Mechanisms of multidrug resistance in HL60 cells: detection of resistance-associated proteins with antibodies against synthetic peptides that correspond to the deduced sequence of P-glycoprotein. D Marquardt, Sue McCrone, Melvin S. Center PubMed Mr 180,000Resistance-associated ProteinsImmunologyMultidrug ResistanceAntimicrobial Chemotherapy	1990	117
Analysis of P-glycoprotein phosphorylation in HL60 cells isolated for resistance to vincristine. D Marquardt, L. Takemoto Journal of Biological Chemistry Molecular RegulationMolecular BiologyCellular PharmacologyP-glycoprotein Polypeptide ChainCellular Physiology	1991	108
Drug transport mechanisms in HL60 cells isolated for resistance to adriamycin: evidence for nuclear drug accumulation and redistribution in resistant cells. D Marquardt, Melvin S. Center PubMed Cellular PharmacologyDrug Transport MechanismsDaunomycin DistributionCellular PhysiologyNuclear Drug Accumulation	1992	93
Characterization of a membrane-associated protein kinase of multidrug-resistant HL60 cells which phosphorylates P-glycoprotein. J Staats, D Marquardt Journal of Biological Chemistry Proteinlipid InteractionMembrane-associated Protein KinaseEnzyme FractionCellular PhysiologyCell Regulation	1990	72
Involvement of Vacuolar H+-Adenosine Triphosphatase Activity in Multidrug Resistance in HL60 Cells D Marquardt JNCI Journal of the National Cancer Institute	1991	67
Multiple mechanisms of adriamycin resistance in the human leukemia cell line CCRF-CEM Tim McGrath, D Marquardt Biochemical Pharmacology Multiple MechanismsMedicineCancer BiologyAdriamycin ResistanceAnti-cancer Agent	1989	24
Use of Designed Peptide Linkers and Recombinant Hemoglobin Mutants for Drug Delivery: <i>In Vitro</i>Release of an Angiotensin II Analog and Kinetic Modeling of Delivery Stephen Trimble, D Marquardt, David C. Anderson Bioconjugate Chemistry	1997	19

Page 1